跳至主要内容
临床试验/NCT04391374
NCT04391374已完成不适用

The Role of Hemostatic Markers of Endothelial Dysfunction in the Development of Disease Progression, Thrombotic Complications and Restenosis in Patients With Atherosclerotic Peripheral Artery Disease

Ryazan State Medical University0 个研究点目标入组 167 人开始时间: 2017年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
167
主要终点
progression of atherosclerosis

研究概览

简要总结

The study is aimed at evaluating the role of the activity of the key hemostatic parameters of endothelial dysfunction (nitric oxide II (NO) metabolites, plasmin activator inhibitor-1 (PAI-1), von Willebrand factor (vWF), coagulation factor VIII (FVIII), soluble endothelial protein C receptors (sEPCR)) in the development of disease progression, thrombotic complications and restenosis in subjects with atherosclerotic peripheral artery disease.

详细描述

The study will involve patients with atherosclerotic peripheral artery disease (Rutherford category 3-5). The subjects are to be divided into three groups:

Group A: patients who undergo bypass surgery with a synthetic graft on aorto-iliac or femoro-popliteal segment; Group B: patients who undergo endovascular balloon angioplasty and stenting on aorto-iliac or femoro-popliteal segment; Group C: patients who undergo standard of care conservative treatment.

Decisions on revascularization or conservative treatment alone is to be made by a team of vascular specialists in accordance with the severity of the disease, previous treatment, anatomy, possible need for repeat procedures in the future, and patient's preferences.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females older than 40 years of age;
  • Presence of peripheral arterial disease of atherosclerotic origin.

排除标准

  • Males or females younger than 40 years of age;
  • Chronic lower limb ischemia of other ethiology (Buerger's disease, aortoarteritis etc.);
  • Active cancer or remission period less than 5 years;
  • Decompensated diabetes mellitus;
  • Pregnancy or breast-feeding for females.

结局指标

主要结局

progression of atherosclerosis

时间窗: 1 year

detection of newly formed or progressing peripheral atherosclerotic lesions

restenosis

时间窗: 1 year

incidence of restenosis in the target arterial segment

thrombosis

时间窗: 1 year

incidence of thrombotic complications in the target arterial segment

次要结局

  • limb salvage rate(1 year)
  • acute myocardial infarction(1 year)
  • mortality rate(1 year)

研究者

申办方类型
Other
责任方
Sponsor

相似试验